Researchers at McMaster University have started a phase-2 clinical trial on a next-generation, inhaled COVID-19 vaccine. The ...

A recently launched Phase 1 clinical trial is examining the safety and feasibility of a groundbreaking treatment approach for Parkinson's disease in which a patient's stem cells are reprogrammed to ...

Personalised medicine advancements are driving the market growth. The clinical trials market is forecasted to reach $99.2b by 2033 with a compound annual growth rate of 6.07% from 2025 to 2033, ...

LINCOLN, Neb.--(BUSINESS WIRE)--Celerion, a global leader in early clinical research, proudly announces a new agreement to relocate its U.K. Phase 1 clinical research operations to iREACH Health.

Alzamend Neuro plans a Phase 2 trial of AL001 for PTSD in late 2025, aiming for better lithium delivery, improved safety, and ...

Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to ... initiating 340+ sites and enrolling 5,000+ participants across all trial ...

Tris Pharma’s first-in-class oral dual-NMR agonist achieved its primary endpoint in the ALLEVIATE-2 study by demonstrating a ...

Biodexa Announces Appointment of Precision for Medicine LLC as CRO for European Component of Phase 3 Study of eRapa in FAP ...

The Phase III clinical studies of JSKN003 for HER2 low-expressing breast cancer ... Multiple clinical studies at various stages of JSKN003 are currently being conducted in China and Australia.

CERo Therapeutics (CERO) announces the execution of an agreement with contract research organization CellCarta to manage translational assays ...